Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patent litigation
Pharma
FTC blasts Teva for 'improper' inhaler patents
After filing a challenge against more than 100 patents in the FDA’s Orange Book, the Federal Trade Commission has singled out Teva in an amicus brief.
Fraiser Kansteiner
Mar 25, 2024 10:04am
Appeals court backs Regeneron's antitrust suit against Novartis
Mar 19, 2024 10:40am
Sandoz wins FDA nods for first Prolia, Xgeva biosimilars
Mar 6, 2024 9:52am
Biogen notches another Tecfidera patent win in Europe
Dec 19, 2023 9:30am
AbbVie files patent litigation against generic Rinvoq makers
Nov 22, 2023 9:04am
FTC takes patent scrutiny to Sanofi, Mylan's insulin case
Nov 21, 2023 11:34am